Very Long Chain Acyl Coa Dehydrogenase Deficiency (vlcadd) - Histology

Relevant Publications

Dental Implications of Very Long-Chain Acyl-CoA Dehydrogenase Deficiency: A Comprehensive Case Report and Literature Review.

Issue Release: 2024

Tracer-based lipidomics enables the discovery of disease-specific candidate biomarkers in mitochondrial β-oxidation disorders.

Issue Release: 2024

Anesthetic Management and Neuromonitoring in a Patient with Very Long-Chain Acyl-Coenzyme A Dehydrogenase Deficiency Undergoing Scoliosis Surgery: A Case Report and Review of Literature.

Issue Release: 2024

[Very-long chain acyl-coA dehydrogenase deficiency: report of a Chinese pedigree and a literature review].

Issue Release: 2024

Remodeling of lipid landscape in high fat fed very-long chain acyl-CoA dehydrogenase null mice favors pro-arrhythmic polyunsaturated fatty acids and their downstream metabolites.

Issue Release: 2023

Very Long-Chain Acyl-CoA Dehydrogenase Deficiency and Type I Diabetes Mellitus: Case Report and Management challenges.

Issue Release: 2023

Heptanoate Improves Compensatory Mechanism of Glucose Homeostasis in Mitochondrial Long-Chain Fatty Acid Oxidation Defect.

Issue Release: 2023

Validation of a targeted metabolomics panel for improved second-tier newborn screening.

Issue Release: 2023

Specifications of the ACMG/AMP guidelines for ACADVL variant interpretation.

Issue Release: 2023

Very-Long-Chain Acyl-CoA Dehydrogenase Deficiency: Family Impact and Perspectives.

Issue Release: 2023

Defects in Very Long-Chain Fatty Acid Oxidation Presenting as Different Types of Cardiomyopathy.

Issue Release: 2022

Very long-chain acyl-CoA dehydrogenase deficiency in a Swedish cohort: Clinical symptoms, newborn screening, enzyme activity, and genetics.

Issue Release: 2022

Screening for newborn fatty acid oxidation disorders in Chongqing and the follow-up of confirmed children.

Issue Release: 2022

Characterization of exonic variants of uncertain significance in very long-chain acyl-CoA dehydrogenase identified through newborn screening.

Issue Release: 2022

Altered Metabolic Flexibility in Inherited Metabolic Diseases of Mitochondrial Fatty Acid Metabolism.

Issue Release: 2021

Very Long-Chain Acyl-CoA Dehydrogenase Deficiency: High Incidence of Detected Patients With Expanded Newborn Screening Program.

Issue Release: 2021

Pervasive inflammatory activation in patients with deficiency in very-long-chain acyl-coA dehydrogenase (VLCADD).

Issue Release: 2021

Abnormal VLCADD newborn screening resembling MADD in four neonates with decreased riboflavin levels and VLCAD activity.

Issue Release: 2021

Electrophysiological Abnormalities in VLCAD Deficient hiPSC-Cardiomyocytes Do not Improve with Carnitine Supplementation.

Issue Release: 2021

Metabolic Outcomes of Anaplerotic Dodecanedioic Acid Supplementation in Very Long Chain Acyl-CoA Dehydrogenase (VLCAD) Deficient Fibroblasts.

Issue Release: 2021

How is Urease Detected in Histological Samples?

Are There Additional Certifications That Can Boost Earnings?

What are the best practices to avoid contamination?

What is RNA Polymerase II?

Are There Any Limitations to Using Blenders in Histology?

How Does Systems Biology Relate to Histology?

What are the Implications of Senescent Cells in Therapeutics?

What Are the Limitations of Histological Examination in Genetic Syndromes?

What is Secretin?

What is the Cockcroft-Gault Equation?

Partnered Content Networks

Relevant Topics